Weight
Tirzepatide
Metabolic
43
Amino acids
Molecular weight
Peptide
Type
Revolutionary dual receptor agonist FDA-approved for type 2 diabetes and chronic weight management. Demonstrates efficacy superior to single-mechanism alternatives with 15-22% body weight reduction in clinical trials. The first-in-class dual GIP/GLP-1 agonist provides enhanced metabolic benefits compared to GLP-1-only medications.
Top researched benefits
Overview of Tirzepatide
Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways.
Weight Loss
- Clinical trials demonstrate 15-22% body weight reduction in non-diabetic obese individuals, superior to existing weight loss medications.
- Improvements in waist circumference, blood pressure, triglycerides, HDL cholesterol, and insulin resistance markers.
- Preferentially reduces visceral adipose tissue while preserving lean muscle mass with resistance training.
Diabetes
- Superior HbA1c reduction of 1.5-2.4% in clinical trials.
- Improves insulin sensitivity across diverse populations.
- May help preserve and restore pancreatic beta cell function.
Cardiovascular
- 26% reduction in major adverse cardiovascular events demonstrated in SURPASS-CVOT trial.
- Systolic and diastolic blood pressure reductions of 8-12 mmHg.
- Triglyceride improvements of 20-30%, HDL enhancement, and apolipoprotein B reduction.
Storage
Pen: 2-8°C before first use, room temp up to 21 days after. Compounded: 2-8°C
Frequency
Once weekly (same day each week)
Typical Dose
2.5mg starting, titrate up to 5-15mg weekly
Cycle Duration
Ongoing therapy as prescribed
Chemical Makeup
Key benefits
Dramatic weight loss (15-22% body weight)
Superior diabetes control
Reduced cardiovascular risk (26% reduction in MACE)
Improved insulin sensitivity
Appetite suppression
Preserved muscle mass with exercise
Community interest
This peptide is still gaining traction in the community.
Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesTirzepatide Molecular Information
View the scientifc details of Tirzepatide.
43
Amino Acids
Tirzepatide
His
His
Position 1
Sec
Sec
Position 2
Glu
Glu
Position 3
Gly
Gly
Position 4
Thr
Thr
Position 5
Phe
Phe
Position 6
Thr
Thr
Position 7
Ser
Ser
Position 8
Asp
Asp
Position 9
Val
Val
Position 10
Ser
Ser
Position 11
Ser
Ser
Position 12
Tyr
Tyr
Position 13
Leu
Leu
Position 14
Glu
Glu
Position 15
Gly
Gly
Position 16
Gln
Gln
Position 17
Ala
Ala
Position 18
Ala
Ala
Position 19
Lys
Lys
Position 20
Glu
Glu
Position 21
Phe
Phe
Position 22
Ile
Ile
Position 23
Ala
Ala
Position 24
Trp
Trp
Position 25
Leu
Leu
Position 26
Val
Val
Position 27
Arg
Arg
Position 28
Gly
Gly
Position 29
Arg
Arg
Position 30
Gly
Gly
Position 31
Gly
Gly
Position 32
Gly
Gly
Position 33
Gly
Gly
Position 34
Gly
Gly
Position 35
Pro
Pro
Position 36
Ser
Ser
Position 37
Lys
Lys
Position 38
Lys
Lys
Position 39
Lys
Lys
Position 40
Lys
Lys
Position 41
Lys
Lys
Position 42
Lys
Lys
Position 43
Molecular Weight
4DaChain Length
43Amino AcidsType
PeptideTirzepatide Protocols
Once-weekly subcutaneous injection. Can be taken any time of day, with or without food. Injection sites include thigh, abdomen (2+ inches from navel), or upper arm.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Weight loss initiation | 2.5 | 4 week range | SubQ injection |
| Weight loss progression | 5 | 1 week range | SubQ injection |
| Weight loss optimization | 7.5 | 1 week range | SubQ injection |
| Maximum weight loss | 12.5 | 1 week range | SubQ injection |
| Diabetes management (mild) | 5 | 1 week range | SubQ injection |
| Diabetes management (severe) | 10 | 1 week range | SubQ injection |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Allow vial to reach room temperature (15-20 minutes)
- Clean vial tops with alcohol wipes, allow air drying
- Calculate reconstitution volume
- Draw bacteriostatic water carefully into syringe
- Insert needle at 45-degree angle against glass wall
- Inject water slowly down vial side to prevent foaming
- Gently swirl—never shake vigorously
- Allow 2-3 minutes for clearing if cloudiness appears
- Final solution must be completely clear and colorless
- Label with date and concentration
- Store at 2-8°C, use within 28 days
Tirzepatide Cycle
The Tirzepatide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Day 1-3
- Appetite reduction begins
- Week 1-2
- Improved blood sugar control (diabetics), mild nausea common
- Week 2-4
- Initial weight loss begins; GI side effects typically improve
- Week 0-0
- 1-3 lbs weight loss per week during active phase
- Week 16-24
- Peak weight loss effects observed
Dosing tools
Tirzepatide Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Tirzepatide
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Tirzepatide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Tirzepatide
- Dosing
- 2.5mg starting, titrate up to 5-15mg weekly
- Dosing Frequency
- Once weekly (same day each week)
- Cycle Duration
- Ongoing therapy as prescribed
- Storage
- Pen: 2-8°C before first use, room temp up to 21 days after. Compounded: 2-8°C
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Tirzepatide interactions with other common peptides and substances.
Weight
5am
Longevity
5-Amino-1MQ
COMPATIBLE
NNMT inhibition may complement GLP-1 effects for metabolic optimization.
Healing
bpc
Longevity
BPC-157
COMPATIBLE
No known interactions, may support gut health and reduce GI effects.
Weight
ipa
Growth
Ipamorelin
COMPATIBLE
May help maintain metabolic rate and muscle preservation.
Weight
sem
Metabolic
Semaglutide
AVOID
Both are GLP-1 agonists—combining increases hypoglycemia and severe GI side effect risk.
Side effects
Avoid: Do not take Tirzepatide with Semaglutide.
Contraindications
Personal or family history of medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Pregnancy or breastfeeding
History of pancreatitis
Stop signs
Severe/persistent abdominal pain (pancreatitis risk)
Neck lumps, hoarseness, difficulty swallowing (thyroid concerns)
Severe nausea/vomiting preventing adequate nutrition
Severe hypoglycemic signs (confusion, sweating, rapid heartbeat)
Kidney problems (decreased urination, swelling)
Severe allergic reactions (rash, breathing difficulty)
Suicidal thoughts or severe depression
Gallbladder problems (severe upper right pain)
Dehydration from persistent vomiting
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
TirzepatideResearch References
Tirzepatide is a fda approved compound
Tirzepatide
Tirzepatide is a fda approved compound
SURMOUNT-1 Phase 3 Trial
15mg weekly achieved 22.5% weight loss vs 2.4% placebo over 72 weeks—largest weight loss in pharmaceutical trials.
2022
SURPASS Clinical Program
Superior HbA1c reduction and weight loss compared to insulin, semaglutide, and existing diabetes medications.
2021
SURMOUNT-2 T2DM Trial
15mg dose achieved 15.7% weight loss with significant cardiometabolic improvements over 72 weeks.
2023
SURPASS-CVOT Cardiovascular Outcomes
26% reduction in major adverse cardiovascular events, establishing cardioprotective benefits.
2023